-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Learjet, September 24, 2021 /PRNewswire/ - LSO MEDICAL SAS, an international leader in vascular laser therapy, today announced that its latest generation EVLT SnakeBack® assist system LUMESEAL laser platform has received CE approval
The third-generation laser system uses the same 1470nm laser design, combined with the RINGLIGHT® fiber range design, and has superior performance and clinical evidence compared with other alternative configurations
"The integration of SnakeBack® technology into LUMESEAL® is a major advancement in the development of this technology
Due to the shortage of semiconductors in the international market, we plan to restrict commercial releases in the fall, which is expected to be fully launched in early 2022
About LSO Medical Corporation
The French LSO medical company has more than 20 years of experience and has a pivotal position, focusing on the design, production and marketing of innovative medical laser systems
LSO Medical is committed to technology research and development, bringing technological innovation to doctors and patients, and is one of the world leaders in today's endothermic laser technology